Showing results (1221-1230 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|January 24, 2004
The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cellsCarmela Fimognari, Michael Nüsse, Renato Iori, et al.
Investigational New Drugs|June 11, 2003
Different effects of vinblastine on the polymerization of isotypically purified tubulins from bovine brainIsrar A Khan, Richard F Ludueña
Investigational New Drugs|June 11, 2003
Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169Thomas H Corbett, Kathryn White, Lisa Polin, et al.
Investigational New Drugs|June 11, 2003
A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" designS M Gadgeel, R R Boinpally, L K Heilbrun, et al.
Investigational New Drugs|June 11, 2003
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancerSanjay Goel, Scott Wadler, Anthony Hoffman, et al.
Investigational New Drugs|June 11, 2003
Current approaches to novel therapeutics in pancreatic cancerCorina E Akerele, Irina Rybalova, Howard L Kaufman, et al.
Investigational New Drugs|November 1, 1992
Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCTB A Murphy, R J Motzer, G J Bosl
Investigational New Drugs|November 1, 1992
Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinomaF V Fossella, R J Winn, P Y Holoye, et al.
Investigational New Drugs|October 31, 2003
Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrinA Bergamo, L Messori, F Piccioli, et al.
Investigational New Drugs|October 31, 2003
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignanciesRobert Wieder, Steven C Novick, Bruce W Hollis, et al.
Pageof 372